4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-20-018003
Director acquired 3,092,340 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nuechterlein Carole Director | 2020-10-20 | Conversion | +2,145,991 | 2,145,991 | I | ||
| Nuechterlein Carole Director | 2020-10-20 | Conversion | +662,799 | 2,808,790 | I | ||
| Nuechterlein Carole Director | 2020-10-20 | Conversion | +283,550 | 3,092,340 | I | ||
| Derivatives | |||||||
| Nuechterlein Carole Director | 2020-10-20 | Conversion · Series A Preferred Stock | −2,145,991 | 0 | I | ||
| Nuechterlein Carole Director | 2020-10-20 | Conversion · Series B-1 Preferred Stock | −662,799 | 0 | I | ||
| Nuechterlein Carole Director | 2020-10-20 | Conversion · Series B-2 Preferred Stock | −283,550 | 0 | I | ||
Loading xslF345X03/doc1.xml…